Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Cardiovascular
Sort By
Newest First
1 / 1
1 / 1
Chronic Diseases
Breaking the Cycle of Chronic Disease with New Therapeutic Strategies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-11
Mar 02, 2025
Ischemia
Battling Ischemia with Therapeutic Angiogenesis
Zhittya Genesis Medicine
PAO-03-22-R250-11
Mar 15, 2022
Accelerated Drug Development for Acute Cardiovascular and Pulmonary Care
Craig Fraser
PA822
Aug 25, 2021
Partnership
BioVectra and PhaseBio Discuss Creating an Optimal Partnership
Oliver Technow; David Alvaro, Ph.D.; Jonathan Mow
BIOVECTRA
PTV-04-21-CL-001
Apr 15, 2021
Clinical Results
AstraZeneca's Drug Significantly Reduces the Rate of the Composite of Stroke and Death in Patients
AstraZeneca
PR-M07-20-NI-027
Jul 16, 2020
Diabetes
Sanofi to Exit Diabetes and Cardiovascular Research
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M12-19-NI-005
Dec 13, 2019
Cell Therapy
CD34+ Cell Therapy in Clinical Trials
Douglas Losordo
Lisata Therapeutics
PAP-Q4-19-CL-012
Dec 06, 2019
M&A
Novartis to Acquire The Medicines Company for $9.7 Billion
Novartis
PR-M11-19-NI-031
Nov 25, 2019
Drug Pricing
Amgen To Make Repatha® (evolocumab) Available Exclusively At Its Lower List Price Option In 2020
Amgen
PR-M10-19-NI-037
Oct 25, 2019
Collaboration Agreement
Sensyne Health Signs Collaboration Agreement with Bayer to Accelerate the Treatments for Cardiovascular Disease Using Clinical Artificial Intelligence
Huma
PR-M08-19-NI-012
Aug 05, 2019
FDA Approval
FDA Approves New Device for Treating Moderate to Severe Chronic Heart Failure in Patients
U.S. Food & Drug Administration
PR-M03-19-NI-068
Mar 25, 2019
Drug Development
Novartis Licenses First-in-Class Heart Disease Drug
Emilie Branch
Pharma's Almanac
PAO-M03-19-NI-008
Mar 05, 2019
Market Prediction
Global Interventional Cardiology Market to Reach $24.96 Billion by 2027
BIS Research
PR-M10-18-NI-098
Oct 29, 2018
Cardiovascular
World Heart Day: Nearly One in Five Deaths From Cardiovascular Disease are Caused by Air Pollution, a Total of 3 Million Deaths Globally Every Year
My Heart, Your Heart
PR-M10-18-NI-013
Oct 03, 2018
Clinical Results
Fish-Oil Drug Shows Dramatic Results in Cardiovascular Study
Emilie Branch
Pharma's Almanac
PAO-M09-18-NI-025
Sep 25, 2018
FDA Approval
Medicure Announces FDA Approval of Acute Care Cardiovascular Drug Sodium Nitroprusside Injection
Medicure
PR-M09-18-NI-020
Sep 10, 2018
Cardiovascular
Janssen Announces Worldwide Development and Commercialization Collaboration with Bristol-Myers Squibb to Advance a Next-Generation Therapy for Cardiovascular Diseases
Janssen Pharmaceutical Companies
PR-M04-18-NI-72
Apr 20, 2018
Results
Positive Results for Pfizer Drug Tafamidis
Emilie Branch
Pharma's Almanac
PAO-M04-18-NI-001
Apr 04, 2018
Innovation
Harvard Researchers Use Chip Technology to Investigate New Anti-inflammatory Drugs
Emilie Branch
Pharma's Almanac
PAO-M01-18-NI-034
Jan 19, 2018
Cardiovascular
Secant Group Develops the First Synthetic Regenerative Cardiovascular Graft
Secant Group
PR-M01-18-NI-052-4856
Jan 16, 2018
